关键信息
-
基因名
CAPN9
- 应用
-
别名
CAPN9；NCL4；Calpain-9
-
种属
Human
-
表达系统
E. coli
-
标签
His tag N-Terminus
-
纯度
Greater than 90% as determined by SDS-PAGE.
-
蛋白编号
O14815
-
表达区间
1-690aa
-
氨基酸序列
MPYLYRAPGP QAHPVPKDAR ITHSSGQSFE QMRQECLQRG TLFEDADFPA SNSSLFYSER PQIPFVWKRP GEIVKNPEFI LGGATRTDIC QGELGDCWLL AAIASLTLNQ KALARVIPQD QSFGPGYAGI FHFQFWQHSE WLDVVIDDRL PTFRDRLVFL HSADHNEFWS ALLEKAYAKL NGSYEALKGG SAIEAMEDFT GGVAETFQTK EAPENFYEIL EKALKRGSLL GCFIDTRSAA ESEARTPFGL IKGHAYSVTG IDQVSFRGQR IELIRIRNPW GQVEWNGSWS DSSPEWRSVG PAEQKRLCHT ALDDGEFWMA FKDFKAHFDK VEICNLTPDA LEEDAIHKWE VTVHQGSWVR GSTAGGCRNF LDTFWTNPQI KLSLTEKDEG QEECSFLVAL MQKDRRKLKR FGANVLTIGY AIYECPDKDE HLNKDFFRYH ASRARSKTFI NLREVSDRFK LPPGEYILIP STFEPHQEAD FCLRIFSEKK AITRDMDGNV DIDLPEPPKP TPPDQETEEE QRFRALFEQV AGEDMEVTAE ELEYVLNAVL QKKKDIKFKK LSLISCKNII SLMDTSGNGK LEFDEFKVFW DKLKQWINLF LRFDADKSGT MSTYELRTAL KAAGFQLSSH LLQLIVLRYA DEELQLDFDD FLNCLVRLEN ASRVFQALST KNKEFIHLNI NEFIHLTMNI
-
分子量
79 kDa
-
内毒素
< 1.0 EU per μg protein as determined by the LAL method.
-
性状
Freeze-dried powder
-
缓冲液
PBS, pH7.4, containing 0.01% SKL, 1mM DTT, 5% Trehalose and Proclin300.
-
复溶方法
Reconstitute in ddH2O to a concentration of 0.1-0.5 mg/mL. Do not vortex.
- 个性化定制
-
稳定性测试
The thermal stability is described by the loss rate. The loss rate was determined by accelerated thermal degradation test, that is, incubate the protein at 37℃ for 48h, and no obvious degradation and precipitation were observed. The loss rate isless than 8% within the expiration date under appropriate storage condition.
-
保存条件 & 期限
Samples are stable for up to twelve months from date of receipt at -20℃ to -80℃. Store it under sterile conditions at -20℃ to -80℃. It is recommended that the protein be aliquoted for optimal storage. Avoid repeated freeze-thaw cycles.
-
运输条件
In general, recombinant proteins are supplied as lyophilized powder and shipped at ambient temperature. For bulk packages, the proteins are provided as frozen liquid and shipped with blue ice, unless otherwise requested by the customer.
质检流程
相关产品
背景信息
CAPN9, a member of the calpain family, is a calcium-dependent cysteine protease that plays a critical role in various cellular processes, including cell differentiation, apoptosis, and migration. Its unique expression pattern, predominantly in digestive tissues, suggests it may be involved in gastrointestinal physiology and pathology. Recent studies have indicated that CAPN9 could be linked to certain cancers, particularly those of the digestive system, highlighting its potential as a biomarker for disease progression and a target for therapeutic intervention. Research into the recombinant expression of CAPN9 has gained momentum as scientists aim to elucidate its functional mechanisms and interactions within cellular environments. By producing recombinant CAPN9, researchers can investigate its enzymatic activity, substrate specificity, and regulatory mechanisms in detail. Furthermore, exploring the role of CAPN9 in signaling pathways may provide insights into its contribution to tumorigenesis and tissue homeostasis. Understanding the structural and functional characteristics of CAPN9 through recombinant technology could pave the way for novel diagnostic and therapeutic strategies, potentially improving outcomes in cancer patients. Overall, the study of CAPN9 not only enhances our comprehension of calpain family members but also holds promise for advancing medical research and therapeutic approaches in the context of gastrointestinal disorders.
